✦ LIBER ✦

Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate

✍ Scribed by Paolo Perseghin; Carlo Gambacorti-Passerini; Lucia Tornaghi; Maria Dassi; Pietro Pioltelli; Matteo Parma; Federica Colnaghi; Giovanni Giudici; Elena Elli; Monica Fumagalli; Luisa Ponchio; Andrea Biondi; Enrico M. Pogliani

Book ID: 109140763
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 89 KB
Volume: 45
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2005.00175.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of imatinib mesylate on normal b

Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response

✍ Fermin M. Sanchez-Guijo; Jesus M. Hernandez; Eva Lumbreras; Patricia Morais; Car 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 418 KB

CD34+/Ph+ cells are still detectable in

CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate

✍ Bocchia, M; Ippoliti, M; Gozzetti, A; Abruzzese, E; Calabrese, S; Amabile, M; Pi 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Molecular responses of late chronic phas

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

✍ YaZhen Qin; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; Yan Zhang; HongHu Zhu; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 117 KB

Successful peripheral blood stem cell mo

Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib

✍ Gabriel, I; Chaidos, A; Sorouri, J; Dannie, E; Davis, J; Goldman, J; Apperley, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Durable responses in chronic myeloid leu

Durable responses in chronic myeloid leukemia patients maintained with lower doses of imatinib mesylate after achieving molecular remission

✍ Angelo Michele Carella; Enrica Lerma 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 88 KB

Prolonged treatment with imatinib mesyla

Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response

✍ E. Cariani; M. Capucci; M. Micheletti; F. Spalenza; I. Zanella; A. Albertini; G. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 114 KB